| Vial description: |
APO3L, DR3LG, APO3 ligand |
| Category: |
primary antibody |
| Clonality: |
monoclonal |
| Raised in: |
Mouse |
| Clone: |
CARL-1 |
| Form: |
Low Endotoxin |
| Reactivity: |
Human |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
O43508 |
| Application: |
F, FN |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
TWEAK / TNFSF12 |
| Short name: |
anti-TWEAK / TNFSF12 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
member 12 (Antibody to), antibody to-TWEAK / tumor necrosis factor (ligand) superfamily |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
APO3L and DR3LG and TWEAK, Extracellular, TNFSF12 and IDBG-408330 and ENSG00000239697 and 8742, TNFSF12 and IDBG-634998 and ENSBTAG00000031725 and 100551513, Tnfsf12 and IDBG-708803 and ENSMUSG00000097328 and 21944, member 12, protein binding, this GO :0001525 and angiogenesis and biological process this GO :0001938 and positive regulation of endothelial cell proliferation and biological process this GO :0005102 and receptor binding and molecular function this GO :0005125 and cytokine activity and molecular function this GO :0005164 and tumor necrosis factor receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006915 and apoptotic process and biological process this GO :0006955 and immune response and biological process this GO :0007165 and signal transduction and biological process this GO :0016020 and membrane and cellular component this GO :0030154 and cell differentiation and biological process this GO :0043542 and endothelial cell migration and biological process this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0048471 and perinuclear region of cytoplasm and cellular component this GO :0097190 and apoptotic signaling pathway and biological process this GO :2001238 and positive regulation of extrinsic apoptotic signaling pathway and biological process, this GO :0005102 : receptor binding, this GO :0005102 : receptor binding and also this GO :0005125 : cytokine activity and also this GO :0005164 : tumor necrosis factor receptor binding and also this GO :0005515 : protein binding, this GO :0005125 : cytokine activity, this GO :0005164 : tumor necrosis factor receptor binding, this GO :0005515 : protein binding, 517833, 788103, tumor necrosis factor (ligand) superfamily |
| Identity: |
11927 |
| Gene: |
TNFSF12 |
More about : TNFSF12 |
| Long gene name: |
tumor necrosis factor superfamily member 12 |
| Synonyms gene name: |
member 12 , tumor necrosis factor (ligand) superfamily |
| Synonyms: |
TWEAK DR3LG APO3L |
| Locus: |
17p13, 1 |
| Discovery year: |
1998-12-04 |
| GenBank acession: |
AF030099 |
| Entrez gene record: |
8742 |
| Pubmed identfication: |
9405449 9560343 |
| RefSeq identity: |
NM_003809 |
| Classification: |
Tumor necrosis factor superfamily |
| Havana BLAST/BLAT: |
OTTHUMG00000108148 |